Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether patient self-report of severe hypoglycemia is associated with increased mortality. RESEARCH DESIGN AND METHODS: Adult patients (N = 1,020) seen in a specialty diabetes clinic between August 2005 and July 2006 were questioned about frequency of hypoglycemia during a preencounter interview; 7 were lost to follow-up and excluded from analysis. Mild hypoglycemia was defined as symptoms managed without assistance, and severe hypoglycemia was defined as symptoms requiring external assistance. Mortality data, demographics, clinical characteristics, and Charlson comorbidity index (CCI) were obtained from the electronic medical record after 5 years. Patients were stratified by self-report of hypoglycemia at baseline, demographics were compared using the two-sample t test, and risk of death was expressed as odds ratio (95% CI). Associations were controlled for age, sex, diabetes type and duration, CCI, HbA1c, and report of severe hypoglycemia. RESULTS: In total, 1,013 patients with type 1 (21.3%) and type 2 (78.7%) diabetes were questioned about hypoglycemia. Among these, 625 (61.7%) reported any hypoglycemia, and 76 (7.5%) reported severe hypoglycemia. After 5 years, patients who reported severe hypoglycemia had 3.4-fold higher mortality (95% CI 1.5–7.4; P = 0.005) compared with those who reported mild/no hypoglycemia. CONCLUSIONS: Self-report of severe hypoglycemia is associated with 3.4-fold increased risk of death. Patient-reported outcomes, including patient-reported hypoglycemia, may therefore augment risk stratification and disease management of patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The primary cause of hypoglycemia is intensification of antihyperglycemic therapy (almost always using SUs [or to a lesser extent glinides] and/or insulin) aimed at achieving lower A1C targets, as demonstrated by intensive therapy trials.1202,1203”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1202]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [195]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An association between selfreported level 3 hypoglycemia and 5-year mortality has also been reported in clinical practice (91).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [91]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587 · cited 1×
“The CCI is an extensively studied and widely used measure that weighs comorbid conditions by the strength of their association with 1-year mortality (17,18); it has been previously validated for use in diabetes (19).”
BackgroundIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Cited by
Items 101–200 of 541
Rickels, M. R., Peleckis, A. J., Dalton-Bakes, C., Naji, J. R., Ran, N. A., Nguyen, H.-L., O’Brien, S., Chen, S., Lee, I., & Schutta, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01516 · Cited by 60
“Once established, hypoglycemia unawareness in T1D is associated with a 20-fold increased risk for experiencing severe hypoglycemia (3), which contributes significantly to disease-related morbidity (4) and mortality (5).”
BackgroundDalal, M. R., Grabner, M., Bonine, N., Stephenson, J. J., DiGenio, A., & Bieszk, N. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.08.004 · Cited by 60
Wilson, D. M., Calhoun, P. M., Maahs, D. M., Chase, H. P., Messer, L. H., Buckingham, B. A., Aye, T., Clinton, P. K., HRAMIAK, I. M., Kollman, C., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0342 · Cited by 60
“Although severe hypoglycemia is associated with adverse events such as seizures and rarely death, less severe nocturnal hypoglycemia is linked to a broad range of adverse consequences,(3) both acutely(4,5) and long term.(6) In a multinational survey of the consequences of nonsevere nocturnal hypoglycemia, Brod et al.”
Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis
Yeh, J. S., Sung, S., Huang, H.-M., Yang, H.-L., You, L., Chuang, S., Huang, P.-C., Hsu, P., Cheng, H., & Chen, C. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0803-3 · Cited by 66
“Therefore, with the increased mortality observed among patients allocated to the intensive treatment versus conventional strategy in the action to control cardiovascular risk in diabetes (ACCORD) trial [8], concerns about the risk of hypoglycemic events have instead been ignited [1, 7, 9–13].”
BackgroundHolmes-Walker, D. J., Gunton, J. E., Hawthorne, W., Payk, M., Anderson, P., Donath, S., Loudovaris, T., Ward, G. M., Kay, T. W., & O'Connell, P. J. (2017) · Transplantation · doi:10.1097/tp.0000000000001381 · Cited by 60
“with those who report mild hypoglycemia.(2) Recurrent severe hypoglycemia is the main indication for islet transplantation.”
BackgroundRickels, M. R., Peleckis, A. J., Markmann, E., Dalton-Bakes, C., Kong, S. M., Teff, K. L., & Naji, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1649 · Cited by 60
The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia
Nordin, C. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0528-0 · Cited by 61
“In one important recent series of 1,020 patients with diabetes followed at the Mayo Clinic [58], patients who reported a single episode of severe hypoglycemia (i.e., hypoglycemia requiring external assistance) were associated with a 3.4-fold increased risk of death over the next 5 years compared with those who had no…”
InfluentialInjectable self-assembled peptide hydrogels for glucose-mediated insulin delivery
Fu, M., Zhang, C., Dai, Y., Li, X., Pan, M., Huang, W., Qian, H., & Ge, L. (2018) · Biomaterials Science · doi:10.1039/c8bm00006a · Cited by 57
Bode, B. W., & Garg, S. K. (2015) · Endocrine Practice · doi:10.4158/ep15869.ra · Cited by 56
Elwen, F. R., Huskinson, A., Clapham, L., Bottomley, M. J., Heller, S. R., James, C., Abbas, A., Baxter, P., & Ajjan, R. A. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000094 · Cited by 55
“8 9 18 19 – 21 It should be stressed that the association between hypoglycemia and mortality does not necessarily indicate causation.”
BackgroundCosts associated with emergency care and hospitalization for severe hypoglycemia
Veronese, G., Marchesini, G., Forlani, G., Saragoni, S., Esposti, L. D., Centis, E., & Fabbri, A. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.01.007 · Cited by 56
Karter, A. J., Lipska, K. J., O’Connor, P. J., Liu, J. Y., Moffet, H. H., Schroeder, E. B., Lawrence, J. M., Nichols, G. A., Newton, K. M., Pathak, R. D., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.009 · Cited by 53
“SH is associated with a tripling of the risk of mortality(Bonds et al., 2010; McCoy et al., 2012; Zoungas et al., 2010) and substantial increases in risk of dementia(Whitmer, Karter, Yaffe, Quesenberry, & Selby, 2009), stroke(Yu, Lin, Chang, Sung, & Kao, 2014), falls(Schwartz et al., 2008),…”
BackgroundInsulin and atherosclerosis: How are they related?
Monnier, L., Hanefeld, M., Schnell, O., Colette, C., & Owens, D. R. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.02.001 · Cited by 66
Cahn, A., Raz, I., Kleinman, Y., Balicer, R., Hoshen, M., Lieberman, N., Brenig, N., Del Prato, S., & Cefalu, W. T. (2015) · Diabetes Care · doi:10.2337/dc15-0187 · Cited by 52
“The association of severe hypoglycemia with morbidity and mortality has been extensively discussed in recent literature, possibly accounting for the emphasis the experts placed upon this parameter (10,11).”
BackgroundCan nanoparticles and nano‒protein interactions bring a bright future for insulin delivery?
Zhang, T., Tang, J. Z., Fei, X., Li, Y., Song, Y., Qian, Z., & Peng, Q. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.016 · Cited by 54
Barranco, R. J., Gomez‐Peralta, F., Abreu, C., Delgado, M., Palomares, R., Romero, F., Morales, C., de la Cal, M. A., Garcia‐Almeida, J. M., Pasquel, F., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12843 · Cited by 50
Borzì, V., Frasson, S., Gussoni, G., Lillo, M., Gerloni, R., Augello, G., Gulli, G., Ceriello, A., Solerte, B., Bonizzoni, E., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.01.020 · Cited by 58
“Hypoglycemia is the most common acute adverse effect of glucose lowering therapy among patients with diabetes mellitus and is associated with poor outcomes and increased mortality [6,11–15].”
BackgroundCHILTON, R. J. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13854 · Cited by 54
Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient‐centered review
Johnson‐Rabbett, B., & Seaquist, E. R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12933 · Cited by 55
“In the major clinical trials (ie, ACCORD and Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation [ADVANCE]), a history of severe hypoglycemia nearly doubled the risk of mortality.(10,11) A prospective clinical-based study of over 1000 patients showed that those with a history of se…”
BackgroundValentine, V., Newswanger, B., Prestrelski, S., Andre, A. D., & Garibaldi, M. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0148 · Cited by 49
The double burden: type 1 diabetes and heart failure—a comprehensive review
Julián, M. T., de, A. P.-M., Julve, J., & Alonso, N. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02136-y · Cited by 55
“In most studies, severe hypoglycemic events have been associated with an increased risk of CVD and all-cause mortality, but data regarding HFoutcomes has not usually been reported [163–167].”
BackgroundMisra-Hebert, A. D., Pantalone, K. M., Ji, X., Milinovich, A., Dey, T., Chagin, K. M., Bauman, J. M., Kattan, M. W., & Zimmerman, R. S. (2018) · Diabetes Care · doi:10.2337/dc17-1834 · Cited by 46
“SH ED visits 3 (38) 2 (29) 2 (29) 4 (12) 3 (7) 4 (9) 7 (10) 5 (6) 4 (4) 12 (12)”
Lawrence, S. E., Albanese-O’Neill, A., Besançon, S., Black, T., Bratina, N., Chaney, D., Cogen, F. R., Cummings, E. A., Moreau, E., Pierce, J. S., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13432 · Cited by 46
“Severe hypoglycemia (loss of consciousness and/or seizures) can lead to injury and, in rare cases, death.(30) School personnel should have clear instructions for managing an episode of severe hypoglycemia.”
BackgroundNationwide reduction in the frequency of severe hypoglycemia by half
The Danish Society for Diabetes in Childhood and Adolescence, Fredheim, S., Johansen, A., Thorsen, S. U., Kremke, B., Nielsen, L. B., Olsen, B. S., Lyngsøe, L., Sildorf, S. M., Pipper, C. B., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0697-5 · Cited by 46
“The patient’s fear of chronic complications is often surpassed by the fear of the unpleasant symptoms accompanying severe hypoglycemia (SH) causing unconsciousness or seizure, and ultimately without intervention, death [1, 2].”
BackgroundHorii, T., Oikawa, Y., Kunisada, N., Shimada, A., & Atsuda, K. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001856 · Cited by 56
Avogaro, A., Dardano, A., de Kreutzenberg, S. V., & Prato, S. D. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12319 · Cited by 49
Kalfon, P., Le Manach, Y., Ichai, C., Bréchot, N., Cinotti, R., Dequin, P.-F., Riu-Poulenc, B., Montravers, P., Annane, D., Dupont, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0851-7 · Cited by 45
“In patients with diabetes, hypoglycemia is widely recognized as a severe adverse event, leading to neurological insult or death [9,10].”
BackgroundZhang, X.-W., Zhang, X.-L., Xu, B., & Kang, L.-N. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1107-1 · Cited by 44
Association of Type 1 Diabetes and Hypoglycemic and Hyperglycemic Events and Risk of Dementia
Whitmer, R. A., Gilsanz, P., Quesenberry, C. P., Karter, A. J., & LACY, M. E. (2021) · Neurology · doi:10.1212/wnl.0000000000012243 · Cited by 49
“However, when they do occur, they are potentially life-threatening and are associated with a range of immediate, dangerous health outcomes, including coma, increased hospitalization, and death.(3)”
BackgroundMuller, N., Khunti, K., Kuß, O., Lindblad, U., Nolan, J. J., Rutten, G. E. H. M., Trento, M., Porta, M., Roth, J., Charpentier, G., et al. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0939-9 · Cited by 44
Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries
Maciejewski, M. L., Mi, X., Sussman, J. B., Greiner, M. A., Curtis, L. H., Ng, J. H., Haffer, S. C., & Kerr, E. A. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4167-y · Cited by 47
Understanding the impact of hypoglycemia on the cardiovascular system
Davis, I., Ahmadizadeh, I., Randell, J., Younk, L. M., & Davis, S. N. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1275960 · Cited by 50
Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home
Donihi, A. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0876-1 · Cited by 45
Carlson, A. L., Kanapka, L. G., Miller, K. M., Ahmann, A. J., Chaytor, N. S., Fox, S., Kiblinger, L., Kruger, D., Levy, C. J., Peters, A. L., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819894974 · Cited by 43
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 57
Han, E., Han, K.-D., Lee, B.-W., Kang, E. S., Cha, B.-S., Ko, S.-H., & Lee, Y.-H. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab860 · Cited by 41
“4-fold increased risk of death independent of diabetes duration or glycated hemoglobin A1c concentration (6).”
BackgroundInsulin Delivery Using Dynamic Covalent Boronic Acid/Ester‐Controlled Release
Banach, Ł., Williams, G. T., & Fossey, J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100118 · Cited by 43
Munshi, M. N., Kahkoska, A. R., Neumiller, J. J., Alexopoulos, A., Allen, N. A., Cukierman‐Yaffe, T., Huang, E. S., Lee, S. J., Lipska, K. J., McCarthy, L. M., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00372-3 · Cited by 48
Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes
Dendy, J. A., Chockalingam, V., Tirumalasetty, N. N., Dornelles, A., Blonde, L., Bolton, P. M., Meadows, R. Y., & Andrews, S. S. (2014) · Endocrine Practice · doi:10.4158/ep13467.or · Cited by 41
Gómez, A. M., Henao, D. C., Madero, A. I., Taboada, L. B., Cruz, V., Gómez, M. A. R., Rondón, M., Múñoz, Ó., Maira, G., & Vargas, F. M. L. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0075 · Cited by 46
Jensen, M. H., Dethlefsen, C., Hejlesen, O. K., & Vestergaard, P. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01447-x · Cited by 45
Prevention of inpatient hypoglycemia with a real‐time informatics alert
Kilpatrick, C. R., Elliott, M. B., Pratt, E., Schafers, S. J., Blackburn, M. C., Heard, K., McGill, J. B., Thoelke, M., & Tobin, G. S. (2014) · Journal of Hospital Medicine · doi:10.1002/jhm.2221 · Cited by 41
Schernthaner, G., Barnett, A. H., Patel, S., Hehnke, U., von Eynatten, M., & Woerle, H. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12321 · Cited by 40
“Recent research has confirmed the dangers of hypoglycaemia and associated its incidence with significantly increased risks for cardiovascular events, death from cardiovascular causes and all-cause mortality [4-9].”
BackgroundMeta-analysis: Association between hypoglycaemia and serious adverse events in older patients
Mattishent, K., & Loke, Y. K. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.018 · Cited by 41
“…Interval 1.68, 2.47) with substantial heterogeneity (chisquared p 0.001, I2=82%)(Bonds et al., 2010, Hsu et al., 2013, Origin Trial AC C EP TE D M AN U SC R IP T Investigators et al., 2013, Khunti et al., 2015, Majumdar et al., 2013, McCoy et al., 2012, Zhao et al., 2012, Zoungas et al., 2010).”
BackgroundInfluentialDeterminants of mortality in patients with type 2 diabetes: a review
Engelmann, J., Manuwald, U., Rubach, C., Kügler, J., Birkenfeld, A. L., Hanefeld, M., & Rothe, U. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9349-0 · Cited by 44
“management [37–41], with self-reported hypoglycemias [42], with non-compliance [43] or with alcohol abuse; also smoking patients as well as patients living in a rural area [26] or with a low socio-economic status (poverty, low income and less access to medical care) [19, 23–25].”
BackgroundBronstone, A., & Graham, C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633233 · Cited by 38
Liu, X., Yu, Y., Liu, D., Li, J., Sun, J., Wei, Q., Zhao, Y., Pandol, S. J., & Li, L. (2022) · NPG Asia Materials · doi:10.1038/s41427-022-00385-5 · Cited by 40
Lucidi, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1065-6 · Cited by 38
Predictors of hypoglycemia in hospitalized patients with diabetes mellitus
Akirov, A., Amitai, O., Masri‐Iraqi, H., Diker‐Cohen, T., Shochat, T., Eizenberg, Y., & Shimon, I. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1787-0 · Cited by 43
Increased risk of stroke in patients with chronic kidney disease after recurrent hypoglycemia
Yu, T., Lin, C., Chang, S., Sung, F., & Kao, C. (2014) · Neurology · doi:10.1212/wnl.0000000000000711 · Cited by 39
The management of severe hypoglycemia by the emergency system: The HYPOTHESIS study
Marchesini, G., Veronese, G., Forlani, G., Forlani, G., Ricciardi, L. M., & Fabbri, A. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.05.012 · Cited by 42
“Severe episodes, defined by the need of external help, may be life-threatening [2], whereas mild iatrogenic events severely impact quality of life [3].”
BackgroundEchouffo-Tcheugui, J. B., Daya, N., Lee, A. K., Tang, O., Ndumele, C. E., Windham, B. G., Shah, A. M., & Selvin, E. (2021) · Diabetes Care · doi:10.2337/dc20-0552 · Cited by 38
“Our findings of the mortality associated with hypoglycemia also extend the literature on this topic (2,31,32) by providing ad-”
Backgroundde Decker, L., Hanon, O., Boureau, A., Chapelet, G., Dibon, C., Pichelin, M., Berrut, G., & Cariou, B. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0319-7 · Cited by 36
Wang, W., Chen, W., Liu, Y., Li, L., Li, S., Tan, J., & Sun, X. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619889322 · Cited by 39
Non-enzymatic glycation mediated structure–function changes in proteins: case of serum albumin
Awasthi, S., & Saraswathi, N. T. (2016) · RSC Advances · doi:10.1039/c6ra08283a · Cited by 41
Dalal, M. R., Kazemi, M. R., Ye, F., & Xie, L. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0592-x · Cited by 37
“Hypoglycemia also contributes to mortality in patients with T2D [19, 20].”
BackgroundClinical results of islet transplantation
Maffi, P., & Secchi, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.010 · Cited by 36
Mohamed, R. S., Marrez, D. A., Salem, S. H., Zaghloul, A. H., Ashoush, I. S., Farrag, A. R. H., & Abdel-Salam, A. M. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01197 · Cited by 35
“Introduction Diabetes mellitus has been and remains one of the most prevalent diseases and one of the most common causes of morbidity and mortality [1, 2].”
BackgroundMarfil‐Garza, B. A., Hefler, J., Verhoeff, K. K., Lam, A. P., Dajani, K. Z., Anderson, B. L., O’Gorman, D., Kin, T., Bello‐Chavolla, O. Y., Grynoch, D., et al. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005783 · Cited by 38
Rhee, C. M., Kovesdy, C. P., You, A. S., Sim, J. J., Soohoo, M., Streja, E., Molnar, M. Z., Amin, A., Abbott, K. C., Nguyen, D. V., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.04.022 · Cited by 35
“73 m2 21 [16-31] 23 [17-33] 21 [16-30] <0.”
Amod, A., Buse, J. B., McGuire, D. K., Pieber, T. R., Pop‐Busui, R., Pratley, R. E., Zinman, B., Hansen, M. B., Jia, T., Mark, T., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00715-x · Cited by 34
Zaccardi, F., Ling, S., Lawson, C. A., Davies, M. J., & Khunti, K. (2020) · Diabetologia · doi:10.1007/s00125-020-05223-3 · Cited by 38
Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
Hanefeld, M., & Bramlage, P. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0366-z · Cited by 36
Residual dysglycemia when at target HbA1c of 7% (53mmol/mol) in persons with type 2 diabetes
Monnier, L., Colette, C., Dejager, S., & Owens, D. R. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.012 · Cited by 32
“Firstly, ensure avoidance of nocturnal hypoglycemic episodes [19–22] and secondly reduce specifically the postmeal glucose”
BackgroundA Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications
Pilla, S. J., Meza, K., Schoenborn, N. L., Boyd, C. M., Maruthur, N. M., & Chander, G. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07828-3 · Cited by 37
Otlivanchik, O., Foll, C. L., & Levin, B. E. (2014) · Diabetes · doi:10.2337/db14-0671 · Cited by 38
Brown, J. B., Reichert, S. M., Valliere, Y., Webster-Bogaert, S., Ratzki‐Leewing, A. A., Ryan, B. L., & Harris, S. B. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0074 · Cited by 38
Engineered insulin-polycation complexes for glucose-responsive delivery with high insulin loading
Volpatti, L. R., Burns, D. M., Basu, A., Langer, R., & Anderson, D. G. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.017 · Cited by 32
Wu, M. S., Carballo‐Jane, E., Zhou, H., Zafian, P., Dai, G., Liu, M., Lao, J. Z., Kelly, T. M., Shao, D., Gorski, J. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28561-9 · Cited by 31
“4 (8), 2 (8), 3 (8), 6 (3), 12 (8) pmol/kg/min; IRPA-7 at 3 (6), 6 (5), 9 (6), 12 (8) and”
Glucose Control in Older Adults With Diabetes Mellitus—More Harm Than Good?
Lipska, K. J., & Montori, V. M. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6189 · Cited by 31
Hypoglycemia as a Driver of Cardiovascular Risk in Diabetes
Moheet, A. A., & Seaquist, E. R. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0351-7 · Cited by 33
Intensive glucose control and hypoglycaemia: a new cardiovascular risk factor?
Rana, O. A., Byrne, C. D., & Greaves, K. (2013) · Heart · doi:10.1136/heartjnl-2013-303871 · Cited by 34
Cooper, M. N., de Klerk, N. H., Jones, T. W., & Davis, E. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12522 · Cited by 30
Wei, W., Zhao, S., Fu, S.-L., Lan, Y., Mao, H., Tan, Q., Xu, P., & Yang, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00536 · Cited by 32
Nishioka, Y., Okada, S., Noda, T., Myojin, T., Kubo, S., Ohtera, S., Kato, G., Kuroda, T., Ishii, H., & Imamura, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13153 · Cited by 28
“11 a-Glucosidase inhibitors 1,940,735 (25) 14,591 (30) 1,926,144 (25) 0.”
Levy-Loboda, T., Sheetrit, E., Liberty, I. F., Haim, A., & Nissim, N. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104129 · Cited by 35
Type 3c: Understanding pancreatogenic diabetes
Vonderau, J. S., & Desai, C. S. (2022) · JAAPA · doi:10.1097/01.jaa.0000885140.47709.6f · Cited by 33
Severe hypoglycemia and falls in older adults with diabetes: The Diabetes & Aging Study
Moffet, H. H., Huang, E. S., Liu, J. Y., Parker, M. M., Lipska, K. J., Laiteerapong, N., Grant, R. W., Lee, A. K., & Karter, A. J. (2023) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2023.100162 · Cited by 29
Jangam, S. R., Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000611 · Cited by 30
Avari, P., Moscardó, V., Jugnee, N., Oliver, N. S., & Reddy, M. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819867688 · Cited by 31
“The burden of hypoglycemia in adults with T1DM is significant and is associated with mortality and morbidity.(9) The mean incidence of mild (self-treated) hypoglycemia is one to two episodes per person per week and severe hypoglycemia (requiring third-party assistance for recovery) is 0·2-3·2 events per person annuall…”
BackgroundGlucagon prescribing and costs among U.S. Adults with diabetes, 2011–2021
Herges, J. R., Galindo, R. J., Neumiller, J. J., Heien, H. C., Umpierrez, G. E., & McCoy, R. G. (2023) · Diabetes Care · doi:10.2337/dc22-1564 · Cited by 28
Self-citationBroos, B., Charleer, S., Bolsens, N., Moyson, C., Mathieu, C., Gillard, P., & De Block, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab188 · Cited by 28
Minimizing Morbidity of Hypoglycemia in Diabetes: A Review of Mini-Dose Glucagon
Chung, S. T., & Haymond, M. W. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814547518 · Cited by 31
Hypoglycemia as an indicator of good diabetes care:
Rodriguez-Gutierrez, R., Lipska, K. J., McCoy, R. G., Ospina, N. S., Ting, H. H., Montori, & Hypoglycemia as a Quality Measure in Diabetes Study Group (2016) · BMJ · doi:10.1136/bmj.i1084 · Cited by 27
Self-citationAlexopoulos, A., Kahkoska, A. R., Pate, V., Bradley, M. C., Niznik, J. D., Thorpe, C. T., Stürmer, T., & Buse, J. B. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.32215 · Cited by 32
A Consensus Perceived Glycemic Variability Metric
Marling, C. R., Struble, N., Bunescu, R., Shubrook, J. H., & Schwartz, F. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700409 · Cited by 31
Optimal Glycaemic Control in Elderly People with Type 2 Diabetes: What Does the Evidence Say?
Mathur, S., Zammitt, N. N., & Frier, B. M. (2014) · Drug Safety · doi:10.1007/s40264-014-0247-7 · Cited by 30
Gomez-Peralta, F., & Abreu, C. (2019) · Drug Design, Development and Therapy · doi:10.2147/dddt.s165372 · Cited by 27
Islet Cell Transplantion: Update on Current Clinical Trials
Schuetz, C., & Markmann, J. F. (2016) · Current Transplantation Reports · doi:10.1007/s40472-016-0103-z · Cited by 34
Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring
Kulzer, B., Freckmann, G., Ziegler, R., Schnell, O., Glatzer, T., & Heinemann, L. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241267823 · Cited by 31
“48 Hypoglycemia is known to be the leading cause of death, especially in young PwD with T1D, although the proportion of NH is unclear.”
Direct-to-consumer strategies to promote deprescribing in primary care: a pilot study
Linsky, A. M., Kressin, N. R., Stolzmann, K. L., Pendergast, J. N., Rosen, A. K., Bokhour, B. G., & Simon, S. R. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01655-5 · Cited by 28
Insulin–Dendrimer Nanocomplex for Multi‐Day Glucose‐Responsive Therapy in Mice and Swine
Xian, S., Xiang, Y., Liu, D., Fan, B., Mitrová, K., Ollier, R. C., Su, B., Alloosh, M. A., Jiráček, J., Sturek, M. S., et al. (2023) · Advanced Materials · doi:10.1002/adma.202308965 · Cited by 29
Verny, C., Doucet, J., Bauduceau, B., Constans, T., Mondon, K., & Floch, J. P. L. (2014) · European Geriatric Medicine · doi:10.1016/j.eurger.2014.10.006 · Cited by 30
“Links between hypoglycemia and cognitive disorders or dementia have been established [28–30].”
BackgroundRoumie, C. L., Min, J. Y., Greevy, R. A., Grijalva, C. G., Hung, A. M., Liu, X., Elasy, T. A., & Griffin, M. R. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.150904 · Cited by 28
Rodriguez-Gutierrez, R., Ospina, N. S., McCoy, R. G., Lipska, K. J., Shah, N. D., Montori, V. M., & for the Hypoglycemia as a Quality Measure in Diabetes Study Group (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5046 · Cited by 24
Self-citationHypoglycemia Patients and Transport by EMS in Alameda County, 2013–15
Moffet, H. H., Warton, E. M., Siegel, L., Sporer, K. A., Lipska, K. J., & Karter, A. J. (2017) · Prehospital Emergency Care · doi:10.1080/10903127.2017.1321707 · Cited by 26
Lin, C., Yeh, N.-C., Wang, J., Ho, C., Her, S.-H., Tsay, W., & Chien, C.-C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa035 · Cited by 24
Kruger, D. F., & Anderson, J. E. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0193 · Cited by 30
“63,64 The increased risk and clinical consequences of hypoglycemia are evidenced in a retrospective study of Medicare beneficiaries of age ‡ 65years from 1999 to2011thatshowed an11.”
Mario, C. D., Genovese, S., Lanza, G. A., Mannucci, E., Marenzi, G., Sciatti, E., Pitocco, D., the Expert Panel Group, Avogaro, A., Bertuzzi, F., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01598-2 · Cited by 26
Roze, S., de Portu, S., Smith‐Palmer, J., Delbaere, A., Valentine, W. J., & Ridderstråle, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.009 · Cited by 25
Metadata
- Authors
- McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A.
- Affiliations
- Mayo Clinic (US)
- Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
- Corresponding author
- Smith, Steven A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-08-14
- Volume
- 35
- Issue
- 9
- Pages
- 1897-1901
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3425008
- OpenAlex
- W2153957843
- Semantic Scholar
- 28fffca9598fb24277bf9ea60849e4ad6060f499
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 34 · 2023: 37 · 2022: 46 · 2021: 35 · 2020: 46 · 2019: 59 · 2018: 36 · 2017: 43 · 2016: 50 · 2015: 49 · 2014: 39 · 2013: 24 · 2012: 3
- FWCI
- 29.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, diabetes mortality, patient self-report, patient-reported outcomes, type 1 diabetes, type 2 diabetes, risk stratification, Charlson Comorbidity Index, HbA1c, diabetes complications
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Male, Retrospective Studies, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.